ROSY-O
People who have completed a previous oncology study with Olaparib are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
- Have participated in a prior oncology study with an AZ compound in which they received Olaparib
- Provide written informed consent
- Are currently deriving clinical benefit from continued treatment in a study using an AstraZeneca compound that has met its endpoints or stopped
You may NOT participate in this study if you:
- Are currently receiving treatment with any prohibited medication(s)
- Have ongoing, Grade 3 or above toxicity that will require interruption of the treatment
- Are currently enrolled in any other type of medical research that is not compatible with this study
Contact Information
Natasha Rambishun, Study Coordinator
1695 Eastchester Road suite 505
Bronx, NY 10461
Phone: (718)-405-8396
Email: NRAMBISH@montefiore.org